ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
The U.S. Department of Veterans Affairs launched a clinical trial evaluating psilocybin for major depression in Veterans, including those with concurrent PTSD. The randomized, controlled trial follows an executive order accelerating psychedelic drug research and approvals.
Tap to vote and see what everyone thinks.
Summary by ByteBrief